Dr. Gieschen on Patient Selection for Radiation in Prostate Cancer

Video

In Partnership With:

Holger L. Gieschen, MD, assistant professor, Department of Radiology, the University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses patient selection for radiation in the treatment of prostate cancer.

Holger L. Gieschen, MD, assistant professor, Department of Radiology, the University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses patient selection for radiation in the treatment of prostate cancer.

There are several patients who are considered eligible to receive radiation therapy, Gieschen says. Patients ranging from low-risk to high-risk disease can be treated with radiation, but there are competing modalities in this space, such as prostatectomy. Although high-risk patients are usually treated with surgery, Gieschen notes that these patients can also benefit from radiation treatment.

In the definitive setting, the goal of radiation therapy is to shrink the cancer as much as possible and potentially cure the patient, whereas in the palliative setting, this approach is used to stabilize prostate-specific antigen levels that naturally rise after surgery.

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine